These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 387838)

  • 21. Testing immunological responses to experimental allografts.
    Hamburger J; Debray-Sachs M; Dimitriu A; Dy M; Caraux J
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):85-91. PubMed ID: 4280168
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of antiserum and complement in the acute antibody-mediated rejection of mouse skin allografts in strain combinations with increasing histoincompatibility.
    Berden JH; Gerlag PG; Hagemann JF; Koene RA
    Transplantation; 1977 Sep; 24(3):175-82. PubMed ID: 339430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indirect evidence of two adverse components of the humoral response to skin allografts as revealed in ALS-suppressed mice.
    Nouza K; Hilgert I; Nĕmec M; Kristofová H
    Folia Biol (Praha); 1972; 18(4):264-9. PubMed ID: 4559929
    [No Abstract]   [Full Text] [Related]  

  • 24. Dynamics of immunologic enhancement.
    Kaliss N
    Transplant Proc; 1970 Mar; 2(1):59-67. PubMed ID: 4940355
    [No Abstract]   [Full Text] [Related]  

  • 25. Activated allogeneic NK cells as suppressors of alloreactive responses.
    Hu B; He Y; Wu Y; Bao G; Liu H; Welniak LA; Murphy WJ
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):772-81. PubMed ID: 20197103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histocompatibility and tooth transplantation in the rabbit.
    Goldstein BH; Tissot RG; Laskin DM; Cohen C
    Oral Surg Oral Med Oral Pathol; 1975 Jun; 39(6):929-33. PubMed ID: 49036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time relationships in the development of immunity to urodele skin allografts transplanted across weak histocompatibility barriers.
    Cohen N
    Transplantation; 1972 May; 13(5):514-20. PubMed ID: 4557799
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum and cell-mediated cytotoxicity after primary and secondary orthotopic tooth transplants among RhLA-paired rhesus monkeys.
    Riviere GR; Tarbox GS
    Transplantation; 1980 Oct; 30(4):290-3. PubMed ID: 6449768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ehancement and hyperacute rejection of skin grafts in the mousefailure to separate cytotoxic and enhancing antibodies from alloantiserum with physicochemical methods.
    Jansen JL; Koene RA; Kamp GJ; Gerlag PG; Wijdeveld PA
    J Immunol; 1975 May; 114(5):1557-62. PubMed ID: 804518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alloreactive cytotoxic anti-H-2 antibodies in sera of the syngeneically immunized C57BL/10ScSnPh, BALB/cJPh, and B10.A/SnPh mice.
    Capková J; Hasek M; Kousalová M; Holán V; Boubelík M
    Folia Biol (Praha); 1983; 29(2):200-8. PubMed ID: 6862049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A histological study of tooth allografts transplanted to untreated and immunologically prepared mice.
    Atkinson ME
    J Oral Pathol; 1975; 4(4):167-79. PubMed ID: 811777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of augmented graft survival in mice after ALS and bone marrow infusion.
    Wood ML; Heppner G; Gozzo JJ; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):691-6. PubMed ID: 4572128
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanisms of marrow graft rejection in murine model systems.
    Dennert G; Knobloch C; Yankelevich B
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):12-7. PubMed ID: 3321640
    [No Abstract]   [Full Text] [Related]  

  • 34. A new in vitro test evaluating anti-lymphocyte serum potency.
    Bach JF; Dardenne M; Dormont J; Antoine B
    Transplant Proc; 1969 Mar; 1(1):403-7. PubMed ID: 4944250
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanisms of immunologic enhancement.
    Amos DB; Cohen I; Klein WJ
    Transplant Proc; 1970 Mar; 2(1):68-75. PubMed ID: 4107294
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunologicc activity of the aged.
    Makinodan T; Perkins EH; Chen MG
    Adv Gerontol Res; 1971; 3():171-98. PubMed ID: 4398644
    [No Abstract]   [Full Text] [Related]  

  • 37. T-cell mediated responses in a murine model of orthotopic corneal transplantation.
    Joo CK; Pepose JS; Stuart PM
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1530-40. PubMed ID: 7601633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of circulating anti-H-2 antibody and cell-mediated precursors in successful DBA/2J-plus-(DBA/2J X C3H/HeJ)F1 parabiosed mice.
    Drell DW; Carlson GA; Wegmann TG
    J Immunol; 1979 Nov; 123(5):2319-27. PubMed ID: 385781
    [No Abstract]   [Full Text] [Related]  

  • 39. Induced immune destruction of long-surviving, H-2 incompatible kidney transplants in mice.
    Russell PS; Chase CM; Colvin RB; Plate JM
    J Exp Med; 1978 May; 147(5):1469-86. PubMed ID: 349112
    [No Abstract]   [Full Text] [Related]  

  • 40. High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice.
    Isakov N; Bach FH
    J Immunol; 1984 Jan; 132(1):50-6. PubMed ID: 6418804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.